Immix BiopharmaIMMX
那斯達克 · USD
13.83
-0.13
(-0.93%)
收盤 09/04 03:59 (UTC+8)
09/04 03:59 (UTC+8)
Immix BiopharmaIMMX
13.83
-0.13
(-0.93%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 12,456 | 10,803 | 10,893 | 7,662 | 6,717 | 4,683 | 4,987 | 7,395 | - | 5,590 |
研發費用 | 5,333 | 5,980 | 5,727 | 4,584 | 3,972 | 1,975 | 1,374 | 4,446 | 2,224 | 3,249 |
推銷及管理費用 | 7,123 | 4,823 | 5,166 | 3,078 | 2,745 | 2,708 | 3,613 | 2,949 | 2,478 | 2,341 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -12,456 | -10,804 | -10,893 | -7,663 | -6,718 | -4,683 | -4,987 | -7,395 | -4,702 | -5,590 |
其他收入及費用 | 914 | 717 | 217 | 85 | 104 | 150 | 186 | 257 | 307 | 268 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -11,543 | -10,087 | -10,677 | -7,578 | -6,614 | -4,533 | -4,801 | -7,138 | -4,396 | -5,322 |
所得稅 | 14 | - | 11 | 8 | 9 | 10 | 11 | 11 | 10 | 9 |
稅後純益 | -11,557 | -10,087 | -10,688 | -7,586 | -6,623 | -4,543 | -4,812 | -7,149 | -4,393 | -5,259 |
基本每股稅後盈餘(元) | -0.18 | -0.18 | -0.28 | -0.24 | -0.22 | -0.15 | -0.15 | -0.24 | -0.15 | -0.22 |
稀釋每股稅後盈餘(元) | -0.18 | -0.18 | -0.28 | -0.24 | -0.22 | -0.15 | -0.16 | -0.24 | -0.14 | -0.22 |
基本平均股數(千股) | 63771.00 | 55369.00 | 40252.00 | 31926.00 | 29983.00 | 29701.00 | 31495.00 | 29424.00 | 28785.00 | 23438.00 |
稀釋平均股數(千股) | 63771.00 | 55369.00 | 40252.00 | 31926.00 | 29983.00 | 29701.00 | 31495.00 | 29424.00 | 28785.00 | 23438.00 |
還原基本每股稅後盈餘(元) | -0.18 | -0.18 | -0.28 | -0.24 | -0.22 | -0.15 | -0.15 | -0.24 | -0.15 | -0.22 |
還原稀釋每股稅後盈餘(元) | -0.18 | -0.18 | -0.28 | -0.24 | -0.22 | -0.15 | -0.16 | -0.24 | -0.14 | -0.22 |
還原基本平均股數(千股) | 63,771 | 55,369 | 40,252 | 31,926 | 29,983 | 29,701 | 31,495 | 29,424 | 28,785 | 23,438 |
還原稀釋平均股數(千股) | 63,771 | 55,369 | 40,252 | 31,926 | 29,983 | 29,701 | 31,495 | 29,424 | 28,785 | 23,438 |
EBITDA(千元) | -11,412 | -9,956 | -10,586 | -7,443 | -6,534 | -4,474 | -4,760 | -7,112 | -4,359 | -5,226 |